Management of Hyperglycemia in the Noncritical Care Setting: A Real-World Case-Based Approach With Alternative Insulin- and Noninsulin-Based Strategies
- PMID: 36561655
- PMCID: PMC9668727
- DOI: 10.2337/dsi22-0012
Management of Hyperglycemia in the Noncritical Care Setting: A Real-World Case-Based Approach With Alternative Insulin- and Noninsulin-Based Strategies
Abstract
Insulin remains the mainstay of treatment for inpatient hyperglycemia in the United States and Canada. However, some other countries commonly use noninsulin agents such as metformin and sulfonylureas, and several trials have demonstrated the efficacy and safety of incretin-based agents in patients with type 2 diabetes who are admitted to noncritical care medicine and surgery services. There is a high degree of interest in alternative glucose-lowering strategies to achieve favorable glycemic outcomes with lower risks of hypoglycemia. In this case series, we highlight the challenges of inpatient glycemic management and the need for alternatives to the traditional basal-bolus insulin regimen. Additional investigation will be imperative to validate the safety and efficacy of appropriate insulin and noninsulin treatments and to further develop guidelines that are applicable in real-world hospital settings.
© 2022 by the American Diabetes Association.
Figures





Similar articles
-
Reliability of Inpatient CGM: Comparison to Standard of Care.J Diabetes Sci Technol. 2023 Mar;17(2):329-335. doi: 10.1177/19322968211062168. Epub 2021 Dec 15. J Diabetes Sci Technol. 2023. PMID: 34911384 Free PMC article.
-
Noninsulin medication therapy for hospitalized patients with diabetes mellitus.Am J Health Syst Pharm. 2018 Sep 15;75(18):1361-1368. doi: 10.2146/ajhp170869. Am J Health Syst Pharm. 2018. PMID: 30190293 Review.
-
Debate on Insulin vs Non-insulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?Curr Diab Rep. 2019 Jul 29;19(9):65. doi: 10.1007/s11892-019-1184-8. Curr Diab Rep. 2019. PMID: 31353426 Review.
-
Addressing hyperglycemia from hospital admission to discharge.Curr Med Res Opin. 2010 Mar;26(3):589-98. doi: 10.1185/03007990903566822. Curr Med Res Opin. 2010. PMID: 20078323 Review.
-
Managing type 2 diabetes: going beyond glycemic control.J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19. J Manag Care Pharm. 2008. PMID: 18597582
Cited by
-
Polyherbal extract improves glycometabolic control in alloxan-induced diabetic rats via down-regulating the MAPK/JNK pathway, modulating Nrf-2/Keap-1 expression, and stimulating insulin signaling.Iran J Basic Med Sci. 2024;27(2):170-179. doi: 10.22038/IJBMS.2023.72553.15780. Iran J Basic Med Sci. 2024. PMID: 38234664 Free PMC article.
References
-
- Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients. In Endotext. Feingold KR, Anawalt B, Boyce A, et al., Eds. South Dartmouth, MA, MDText.com, 2000 - PubMed
-
- Swanson CM, Potter DJ, Kongable GL, Cook CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract 2011;17:853–861 - PubMed
-
- Umpierrez GE, Hellman R, Korytkowski MT, et al. .; Endocrine Society . Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16–38 - PubMed
-
- Umpierrez GE, Smiley D, Zisman A, et al. . Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007;30:2181–2186 - PubMed